Ph2, Study to Assess the Safety and Efficacy of GPC 100 and Propranolol With and Without G-CSF for the Mobilization of Stem Cells in Patients With Multiple Myeloma Undergoing Autologous Stem Cell Transplant
Condition: Multiple Myeloma Interventions: Drug: GPC-100; Drug: Propranolol; Drug: G-CSF Sponsor: GPCR Therapeutics, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 30, 2022 Category: Research Source Type: clinical trials
